PillRx only · Injection · Subcutaneous
Epinephrine
Epinephrine
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$116.711
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
7
Active US suppliers
53%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
139K
Rx · 2026 Q1
305K
Units dispensed
+9%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Asclemed USA, Inc. | unknown | 5 | SUPPLYING |
| Amneal Pharmaceuticals of New York LLC | unknown | 4 | SUPPLYING |
| Sportpharm LLC | unknown | 2 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 2 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 2 | SUPPLYING |
| ADVANCED RX PHARMACY OF TENNESSEE, LLC | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.